The Physician Who Didn't Want to Sell - Until They Did

I once had a conversation with a physician founder who told me - politely but firmly - that he had zero interest in selling. Built the practice from scratch. Twenty-plus years. His name was on the building.

Eight months later, he called back. Same practice, same physician, completely different posture. What changed had nothing to do with us. His junior partner left. His lease renewal was 14 months out. And a PE-backed competitor had just acquired the largest group in his market, which meant his referral relationships were about to get complicated.

Three triggers stacked on top of a readiness he hadn't fully admitted to himself.

That pattern plays out constantly in physician practice M&A. The physicians who sell almost never start the process because a banker called at the right moment. They start because something in their operating environment shifted, and someone they already trusted was positioned to have the conversation.

The teams that consistently win proprietary deals are reading those signals before the physician picks up the phone.

Nearly half of active clinical physicians in the U.S. are now 55 or older, with one in five over 65, according to the AAMC’s Physician Workforce Data Dashboard. The retirement wave has been discussed for years. But physicians don't sell because they hit a birthday. They sell because a trigger event converts latent readiness into active motivation.

Here are the signals that, across every deal I've worked on, most reliably predict a physician is 6-18 months from a real conversation.

A solo founder over 60 with no junior partners is the clearest signal in physician practice M&A. But the nuance matters. A 62-year-old with two associate physicians and a strong practice administrator has a succession path. A 62-year-old whose partners are the same age does not. The question isn't just "how old is the founder?" - it's "who runs this practice if the founder stops showing up tomorrow?"

State medical board records, NPI registry data, and practice websites all show physician rosters. When a group drops from four names on the "Our Team" page to three, that's a data point most teams miss entirely.

This one surprises people. Medical office leases typically run 10-15 years, significantly longer than standard commercial. When a physician founder is 18 months from a lease expiration or renewal decision, the calculus changes. Renewing means committing to another 10-year term. For a 63-year-old, that's committing to practice until 73. That math tends to clarify things.

Here's the part most sourcing teams don't realize: in many jurisdictions, lease term dates are accessible through public records. When commercial leases are recorded at the county level, the memorandum of lease - a short-form document filed for public notice - discloses commencement and expiration dates. A number of states require recording for leases above a certain term length. Coverage varies by county, and not every lease gets recorded. But for the leases that are, you can build a timeline of renewal windows across your entire target universe without ever making a phone call.

Nobody I've talked to in healthcare deal sourcing is doing this systematically.

When a partner leaves a group practice - whether for retirement, relocation, or a competing platform - the remaining physicians absorb more patients, more call coverage, and more administrative burden. The practice doesn't necessarily get smaller. It gets harder.

I've watched this dynamic accelerate sale timelines by 12-18 months. The founder who was "three years away" suddenly has to cover weekends and rethink the call schedule. The financial profile of the practice may still look fine. The physician's quality of life does not.

Practice websites, state licensing databases, and NPI records all surface these changes. The teams that are monitoring for them catch the signal while the banker is still building the pitch deck.

When a PE-backed platform acquires the largest independent group in a physician's market, every other independent in that geography starts having a different internal conversation. Their referral relationships are now running through a platform. Their negotiating leverage with payers just shifted. The competitive landscape they've operated in for 20 years changed overnight.

This is where the "not interested" physician becomes "tell me more." Not because they suddenly want to sell. Because they're processing what the market looks like in three years if they don't.

PwC's 2026 healthcare deals outlook notes that mid-market dealmakers face greater pricing pressure from well-capitalized PE funds accelerating deal timelines. When the platforms are moving faster, the independents feel it.

Policy shifts create urgency that no amount of relationship-building can replicate. The IRA drug price negotiations have already produced discounts of up to 79% on the first cohort of Medicare drugs, with physician-administered Part B drugs entering negotiations for the first time in 2028. For independent oncology practices relying on drug margin to fund their independence, that's a direct hit to the revenue model.

Site-neutral payment reform, Medicare Advantage rate pressure, and payer contract renewal cycles all create windows where the economics of independence get harder to justify. The physicians who understand this - and the sophisticated ones do - start thinking about timing.

Nobody puts "my spouse told me I'm done" in a press release. But having sat across the table from enough physician founders, I can tell you it's behind more transactions than any reimbursement change.

Burnout. A health scare. Kids finishing college. A spouse who's ready for the next chapter. These triggers don't show up in any database. But they're often the actual catalyst that converts a physician from "maybe someday" to "let's have a real conversation."

You can't scrape for these. But when you've been in a relationship with a physician for 12 months and they mention their youngest just started medical school, that's a signal. The teams that are in the relationship early enough to hear it are the ones who get the call.

Knowing these signals exist is not the hard part. Every experienced deal professional has seen these patterns play out.

The hard part is building a system that tracks them across 200+ prospects simultaneously and surfaces the ones where multiple signals are converging. The founder who's 63, whose junior partner just left, whose lease renews in 16 months, and whose largest competitor just got acquired - that's a four-signal convergence. That physician is having the conversation with someone in the next 12 months. The question is whether it's you.

Most teams don't have this infrastructure. They're checking LinkedIn manually and relying on the banker to call when the process launches. By then, they're bidding in an auction with four other groups who got the same CIM on the same Tuesday.

The latest SPS Origination Benchmark Report found that the median PE firm covers just 17.6% of its target market deal flow. The other 82% of deal flow never crossed their desk.

We recently built a market and sourcing map for a client that layered successional signals, lease term windows, partner movement tracking, and competitive consolidation monitoring across their full prospect universe. The output included physician-level enrichment - training backgrounds, estimated ages derived from career timelines, NPI-verified practice footprints, and entity verification through state corporate filings. Every prospect came with approach notes tailored to the specific physician's profile and likely motivation.

The deliverable looked more like a prioritized pipeline with timing intelligence built in than anything you'd get from a database export.

If you're building a healthcare platform or running sell-side origination and the signals we're describing here resonate with how deals actually happen in your experience - I'd welcome the conversation.

Book a call | LinkedIn | Healthcare M&AI

-Shawn

What's the trigger you've seen most often that converts a "not now" physician into an active seller? Reply to this email - I read every response.

This newsletter is for informational purposes only and does not constitute investment, legal, or financial advice.